Science - CRS. Experts. Early Phase.

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

. 25. Mai 2023

Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.

. 25. Mai 2023

Appetite Ghrelin Ghrelin-O-acyltransferase pharmacodynamics pharmacokinetics tolerability

(Bersacapavir) In Participants With Moderate Hepatic Impairment.

. 25. Mai 2023

clinical pharmacology hepatic impairment hepatitis B viral hepatiti

Discordance between estimated and measured changes in plasma volume among patients with acute heart failure.

. 25. Mai 2023

Acute heart failure Estimated plasma volume (ePV)Haematocrit Measured plasma volume (mPV)Strauss‘ formula

Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.

. 30. Januar 2023

bioequivalence fixed-dose combination macitentan pulmonary arterial hypertension tadalafil

Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.

. 30. Januar 2023

CYP3A drug-drug interactions early clinical development microdosing midazolam

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.

. 30. Januar 2023

interaction ombined oral contraceptive selective progesterone receptor modulator

Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton’s tyrosine kinase, in Phase I clinical trials in healthy volunteers.

. 30. Januar 2023

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.

. 30. Januar 2023

Diabetic Macular Edema in Diabetological Practices.

. 30. Januar 2023

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

. 30. Januar 2023

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses.

. 30. Januar 2023

CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.